Jairo Cruz, DPM
Podiatrist · Zephyrhills, FLNPI 1609163153
Payments from drug & device makers
What this record shows
This record is dominated by other: $16,181 of the $21,240 with a category attached, or 76.2%. Convatec Inc. accounts for 75.4% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2024 at $16,264 and has fallen 97.5% since, to $401 in 2025. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 169 payments — averaging $125.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$16K
- Stryker$1K
- Smith+Nephew$1K
- Organogenesis Inc.$514
- Crossroads Extremity Systems, LLC$424
- Integra Lifesciences Corporation$304
- plus $1K from 27 others
What the payments were for
- Travel & lodging$1,2816%
- Food & beverage$3,77818%
- Other$16,18176%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 4 | $16,017 |
| Stryker(2 entities) | 17 | $1,381 |
| Smith+Nephew | 28 | $1,161 |
| Organogenesis Inc. | 22 | $514 |
| Crossroads Extremity Systems, LLC | 3 | $424 |
| Integra Lifesciences Corporation | 9 | $304 |
| Paratek Pharmaceuticals, Inc. | 18 | $227 |
| Amgen | 13 | $199 |
| Zyla Life Sciences, Inc. | 13 | $176 |
| Nevro Corp. | 7 | $135 |
| Kerecis Limited | 4 | $109 |
| KCI USA, Inc. | 3 | $58 |
| Next Science LLC | 2 | $48 |
| Bioventus LLC | 3 | $43 |
| Sanara Medtech Inc. | 1 | $35 |
| Medela LLC | 1 | $35 |
| Zimmer Biomet | 1 | $35 |
| Averitas Pharma Inc. | 2 | $34 |
| Orthofix Medical, Inc. | 2 | $32 |
| Triad Life Sciences Inc. | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| MVP Orthopedics Inc | 2 | $25 |
| Sandoz | 1 | $25 |
| Treace Medical Concepts, Inc. | 1 | $22 |
| Hartmann USA, Inc. | 1 | $22 |
| Orpyx Medical Technologies US Inc. | 1 | $21 |
| AbbVie | 1 | $18 |
| ETS Wound Care LLC | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $14 |
| Medtronic | 1 | $14 |
| Mimedx Group, Inc. | 1 | $13 |
| GRT US Holding, Inc. | 1 | $13 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$16,000
- Grafix$725
- Oasis$725
- PICO$725
- RENASYS TOUCH$725
- Versajet$725
- ANCHORAGE$494
- VARIAX$306
- PuraPly$232
- INTEGRA$181
- COLLAGENASE SANTYL$121
- ALLOWRAP$113
How this compares
$21,240 in reported general payments places this provider in the 95th percentile of 588 podiatrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuzyraOmadacycline Tosylate | 16 | $81,191 |
| JubliaEfinaconazole | 14 | $15,599 |
| Ciclopirox | 60 | $2,370 |
| Ketoconazole | 43 | $1,278 |
| Doxycycline Hyclate | 63 | $485 |
| Mupirocin | 33 | $305 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Paratek Pharmaceuticals, Inc.Nuzyra | $227 | $81,19116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 588 podiatrist providers in Florida.
Other podiatrist in Zephyrhills
- Isin MustafaZephyrhills$13K
- James CottomSarasota$1.8M
- Caroline KiserFleming Island$206K
- Adam PerlerLargo$160K
- Desmond BellJacksonville$125K
- Jeffrey KarrLakeland$101K
- Marie WilliamsAventura$96K
- Todd BrennanTampa$88K
- Robert HooverLake Mary$71K
- Daniel BrandweinPompano Beach$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.